A 2026 BMJ study found GLP-1 drugs like Ozempic carry a 37–68% higher alopecia risk vs. other diabetes medications. The post ...

It started as a routine phonics lesson in the 1st grade Bronx classroom I was observing to study how students learn to read.

Millions of people with type 2 diabetes take a common class of blood pressure pill called dihydropyridine calcium channel ...

NFL teams have been anticipating the 2027 draft for a few years. But is this class really as good as they say? We asked ...

The Delhi High Court has observed that students who spend “hours and months” preparing for admission to premier institutions ...

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Regeneron Pharmaceuticals, Inc. ("“Regeneron” or the “Company”) (NASDAQ: REGN) and reminds ...

Arcus Biosciences, Inc. (NYSE: RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer and ...

The risk of hair loss in patients taking GLP-1 drugs for obesity or diabetes, while low, is higher than with other diabetes ...

The study also shows that moderate to severe injuries were more common among e-bike riders than traditional bicyclists.

BusesForSale reports that school field trips are declining due to budget cuts and a shortage of bus drivers, affecting students' cultural exposure and learning.

Global Expansion Complete as Germany Joins Ongoing Study of Inhaled LTI-03 in Idiopathic Pulmonary FibrosisCompany on track to report initial topline data in 2H 2026 AUSTIN, Texas, July 21, 2026 ...

A new study looking at nearly 877,000 people with type 2 diabetes found that patients who used GLP-1 medications had a higher risk of developing issues with their sense of smell and taste compared to ...